Novel treatment of opioid use disorder using ibogaine and iboga in two adults
Outcomes Case report moderate
AI-extracted · unverified · confirm at source
Two Canadian OUD cases: Case 1 achieved total opioid abstinence (3yr+) after single treatment. Case 2 used multiple iboga sessions to taper off OAT, maintained 2yr+ abstinence. Demonstrates treatment versatility.
Dosing: variable - flood dose protocol over 6 days (oral)
Sample size: 2
Safety data present: QTC